𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of low-dose, intermittent eel calcitonin treatment for osteoporosis

✍ Scribed by Yoshiki Nishizawa; Satoshi Hagiwara; Kiyoshi Nakatsuka; Hideyuki Aratani; Takami Miki; Hirotoshi Morii

Publisher
Springer
Year
1995
Tongue
English
Weight
278 KB
Volume
13
Category
Article
ISSN
0914-8779

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Successful treatment of low turnover ost
Successful treatment of low turnover osteoporosis resulting from prolonged reserpine therapy with intermittent calcitonin and phosphate therapy
✍ Reina C. Armamento-Villareal; Louis V. Avioli πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 238 KB

Coherence therapy, popularly known by the acronym ADFR (Activate, Depress, Free, Repeat), was designed to increase bone mass in osteopenic patients. Accordingly, we report a case of a hypogonadal male with histologically proven low bone turnover osteoporosis and a progressive vertebral fracture synd

Efficacy of low-dose topotecan in second
Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma
✍ Bo Gronlund; Heine H. Hansen; Claus HΓΈgdall; Svend A. Engelholm πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

## Abstract ## BACKGROUND The high incidence of dose‐limiting myelosuppresion using the U.S. Food and Drug Administration‐approved topotecan dose of 1.5 mg/m^2^ for 5 days every 3 weeks may have limited its utility in the treatment of patients with epithelial ovarian carcinoma. The objective of th